Latest

psychopharmacology

·November 9, 2021·5 min read

New Imaging Biomarkers That Predict Antidepressant Response Identified

Combining neuroimaging and artificial intelligence, researchers identified novel brain signatures unique to the response of each antidepressant.

Featured Neuroscience Open Neuroscience Articles Psychology

·November 8, 2021·4 min read

Expectations and Dopamine Can Affect Outcome of SSRI Antidepressant Treatment

The placebo effect combined with dopamine levels can determine whether symptoms of depression and social anxiety will improve in patients prescribed SSRI antidepressants. Researchers found the positive effect of the medications was four times higher in patients with high expectations the treatment would work compared to those with lower expectations.

Featured Neurology Neuroscience

·October 22, 2021·4 min read

Common Antidepressant Should No Longer Be Used to Treat People With Dementia

Mirtazapine, an antidepressant commonly prescribed to treat dementia-associated agitation, is no more effective than a placebo and may increase mortality risks, researchers report.

Auditory Neuroscience Featured Neuroscience Psychology

·October 5, 2021·4 min read

Psilocybin Affects Perception of Music

Psilocybin, a natural psychoactive compound currently being considered for the treatment of depression, alters people's emotional states while listening to music. While listening to music, those who used psilocybin reported enhanced emotional processing. Researchers say combining music with psychedelic therapy may have positive benefits for those suffering from depression.

Featured Neuroscience Open Neuroscience Articles Psychology

·September 27, 2021·4 min read

Psychedelics Linked to Social Bonding and Prosocial Behaviors in Ravers

Drums, dance, sleep deprivation, and drugs, referred to as the 4D's in the rave scene was associated with personal transformation for those who considered a rave to be an awe-inspiring event. The more a person felt personally transformed by the experience, the more bonded to the fellow ravers they felt. This phenomenon may explain the long-standing popularity of the rave scene.

Featured Neuroscience Psychology

·August 23, 2021·5 min read

Prozac Changes Fat Composition of the Brain

Prozac reduced polyunsaturated fatty acid lipid concentrations in the brains of juvenile macaque monkeys.

Featured Neuroscience Open Neuroscience Articles Psychology

·August 11, 2021·4 min read

New Findings on How Ketamine Prevents Depression

A new study provides novel mechanistic insights into how ketamine exerts its antidepressant effects for those with depression.

Featured Neuroscience Open Neuroscience Articles Psychology

·August 7, 2021·4 min read

Nutritional Supplements Could Help Treat PTSD

Combining two natural products that modulate the epigenome, researchers believe they have identified a feasible approach to reversing symptoms of PTSD in animal models that could be effective in humans.

This shows an outline of a child and ADHD

Featured Neuroscience Psychology

·July 29, 2021·5 min read

ADHD Drug Class Leads to Fewer Side Effects in Preschool Children

Alpha-2-adrenergic agonists appear to be effective at reducing symptoms associated with ADHD in preschool-aged children, and have fewer side effects than traditional stimulants used to treat ADHD.

Featured Genetics Neuroscience Psychology

·July 28, 2021·3 min read

Discovery Points to Ketamine’s Long-Term Antidepressant Effects

The MeCP2 gene influences ketamine's behavioral effect and strengthens synapses, leading to an improvement in the drug's antidepressant effect over time.

Featured Neuroscience Pain Psychology

·July 25, 2021·4 min read

The Future of Psychedelic Science

From treating depression and other mental health disorders, to helping relieve chronic pain, researchers discuss the advantages and implications of psychedelic treatments.

Featured Neuroscience Psychology

·July 7, 2021·4 min read

Work Like a Dream: New Anticholinergic Drug Keeps PTSD Flashbacks and Nightmares Away

Trihexyphenidyl, an anticholinergic medication commonly prescribed for Parkinson's symptoms, appears to alleviate negative memory flashbacks and nightmares experienced by those with PTSD.